ClearPoint Neuro, Inc.CLPT
Price (close)
$14.83
Market cap
$452.4M
P/E
—
Revenue (TTM)
$42.3M
Net income
-$34.6M
Dividend yield
—
1-year total return
-24.9%
Net margin
-81.8%
Revenue growth
25.9%
Debt / equity
4.66x
What ClearPoint Neuro, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $12.8M | $16.3M | $20.6M | $24.0M | $31.4M | $37.0M |
| Net income | -$6.8M | -$14.4M | -$16.4M | -$22.1M | -$18.9M | -$25.5M |
| Free cash flow | -$7.8M | -$12.9M | -$16.4M | -$14.4M | -$9.2M | -$24.4M |
More on CLPT.
- ClearPoint Neuro, Inc. summary
- ClearPoint Neuro, Inc. financial statements
- ClearPoint Neuro, Inc. key metrics
- ClearPoint Neuro, Inc. health scores and style box
- ClearPoint Neuro, Inc. earnings
- ClearPoint Neuro, Inc. dividends
- ClearPoint Neuro, Inc. valuation
- ClearPoint Neuro, Inc. ownership and insiders
- ClearPoint Neuro, Inc. peers
Figures from ClearPoint Neuro, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.